PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
April 30, 2007Arthritis Care & Research315 citations

Churg‐Strauss syndrome with poor‐prognosis factors: A prospective multicenter trial comparing glucocorticoids and six or twelve cyclophosphamide pulses in forty‐eight patients

View Full Paper
PCPascal CohenCPChristian PagnouxAMAlfred Mahr

Key Points

Key points are not available for this paper at this time.

Abstract

We concluded that 12 cyclophosphamide pulses were better able to control severe CSS than a 6-pulse regimen. The optimal duration of therapy remains to be determined.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Cohen et al. (2007) studied this question.

synapsesocial.com/papers/69d8c356ce048d2571bee23ahttps://doi.org/10.1002/art.22679
Ask AI
Helpful
Bookmark
Share
View Full Paper